Menu
← Oncology Approval Tracker
FDA DECISION ·
Romidepsin (generic Istodax)
romidepsin · Fresenius Kabi
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
First generic romidepsin injection for adults with cutaneous T-cell lymphoma following at least one prior systemic treatment.
LAMPGEN ANALYSIS
Why it matters
The ANDA action applies to cutaneous T-cell lymphoma after prior therapy.
What research teams should watch
Confirm cutaneous histology and previous systemic therapy before applying the generic label.
PRIMARY RECORDS